Studying the Molecule, Assuming the Experience: The Pharmacology–Experience Asymmetry Framework for Psychedelic Research
ACS Pharmacology & Translational Science September 11, 2026 Damián Pobihuszka
Abstract Contemporary models of psychedelic action hold that clinical outcomes arise from an interaction between a pharmacologically induced brain state and the lived experience that unfolds within it. Research effort is distributed very unevenly across those two domains: pharmacological variables receive dose-finding trials, power calculations, and effect-size estimates, while the variables...